Biostem Technologies Inc
OTC:BSEM

Watchlist Manager
Biostem Technologies Inc Logo
Biostem Technologies Inc
OTC:BSEM
Watchlist
Price: 13.55 USD -6.16% Market Closed
Market Cap: 221.4m USD
Have any thoughts about
Biostem Technologies Inc?
Write Note

Wall Street
Price Targets

BSEM Price Targets Summary
Biostem Technologies Inc

Wall Street analysts forecast BSEM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BSEM is 33.15 USD with a low forecast of 32.83 USD and a high forecast of 34.13 USD.

Lowest
Price Target
32.83 USD
142% Upside
Average
Price Target
33.15 USD
145% Upside
Highest
Price Target
34.13 USD
152% Upside
Biostem Technologies Inc Competitors:
Price Targets
AUROPHARMA
Aurobindo Pharma Ltd
25% Upside
LQDA
Liquidia Corp
126% Upside
4015
Jamjoom Pharmaceuticals Factory Company SJSC
13% Upside
VRNA
Verona Pharma PLC
6% Upside
300357
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd
28% Upside
FULC
Fulcrum Therapeutics Inc
15% Upside
REC
Recordati Industria Chimica e Farmaceutica SpA
10% Upside

Revenue
Forecast

Revenue Estimate
Biostem Technologies Inc

For the last 12 years the compound annual growth rate for Biostem Technologies Inc's revenue is 23%. The projected CAGR for the next 2 years is 348%.

23%
Past Growth
348%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Biostem Technologies Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Biostem Technologies Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BSEM's stock price target?
Price Target
33.15 USD

According to Wall Street analysts, the average 1-year price target for BSEM is 33.15 USD with a low forecast of 32.83 USD and a high forecast of 34.13 USD.

What is Biostem Technologies Inc's Revenue forecast?
Projected CAGR
348%

For the last 12 years the compound annual growth rate for Biostem Technologies Inc's revenue is 23%. The projected CAGR for the next 2 years is 348%.

Back to Top